Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 12, 2023Frontiers in Cellular NeuroscienceOpen Access

The AMPK activator metformin improves recovery from demyelination by shifting oligodendrocyte bioenergetics and accelerating OPC differentiation

View Full Paper
Ask AI
Bookmark
Share

Authors

MNMohanlall NarineMAMaryam A. AzmiMUMartin Umali

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Narine et al. (2023) studied this question.

synapsesocial.com/papers/6a79bd3d684c0941cf321eb2https://doi.org/10.3389/fncel.2023.1254303
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex2014 · 5,507 citations
  2. 2Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin2011 · 377 citations
  3. 3Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)2011 · 1,551 citations
  4. 4Cholesterol biosynthesis defines oligodendrocyte precursor heterogeneity between brain and spinal cord2022 · 56 citations